A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback